Despite Gail being inadequate and not approved by either the National Comprehensive Cancer Network (NCCN) or the American Cancer Society (ACS) guidelines, some insurance companies do accept it.

The right models are BRCAPRO, Tyrer Cuzick and Claus.  Boadicea has potential (And is accepted by the NCCN guidelines) but it is not much different from BRCAPRO and requires separate data entry.

Share This